Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening

The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans. Beta-lactams tested were effective alone and displayed a strong synergistic profile in combination with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Arenaz-Callao, María Pilar, González del Río, Rubén, Lucía Quintana, Ainhoa, Thompson, Charles J., Mendoza-Losana, Alfonso, Ramón-García, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366712/
https://www.ncbi.nlm.nih.gov/pubmed/30689630
http://dx.doi.org/10.1371/journal.pntd.0007126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366712/
https://www.ncbi.nlm.nih.gov/pubmed/30689630
http://dx.doi.org/10.1371/journal.pntd.0007126

Ejemplares similares